![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Centessa Pharmaceuticals PLC | NASDAQ:CNTA | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.36 | -3.16% | 11.04 | 11.08 | 11.67 | 11.61 | 10.95 | 11.42 | 332,516 | 01:00:00 |
A live audio webcast of this event can be accessed on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations. Replay of the webcast will be archived on the Company's website for 90 days following the event.
About Centessa PharmaceuticalsCentessa Pharmaceuticals plc aims to bring impactful new medicines to patients by combining the strengths of an asset-centric model with the benefits of scale and diversification typical of larger R&D organizations. The asset-centric model refers to a highly specialized, singular-focused company that is led by a team of well-recognized subject matter experts. Centessa’s asset-centric companies’ programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. For more information, visit www.centessa.com.
Contacts:
Investor Contact: | Media Contacts: |
Jennifer Porcelli, Head of Investor Relations | US |
Centessa Pharmaceuticals | Dan Budwick, 1AB |
jennifer.porcelli@centessa.com | dan@1abmedia.com |
UK/Greater Europe | |
Mary Clark & Shabnam Bashir, Optimum Strategic Communications | |
centessa@optimumcomms.com | |
Switzerland | |
Marcus Veith, VEITHing Spirit | |
marcus@vspirit.ch | |
M: +41 79 20 75 111 |
1 Year Centessa Pharmaceuticals Chart |
1 Month Centessa Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions